| 000 | 00966 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517031435.0 | ||
| 264 | 0 | _c20160108 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1744-7607 | ||
| 024 | 7 |
_a10.1517/17425255.2015.1041255 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeters, Godefridus J | |
| 245 | 0 | 0 |
_aDrug transport and metabolism of novel anticancer drugs. _h[electronic resource] |
| 260 |
_bExpert opinion on drug metabolism & toxicology _cMay 2015 |
||
| 300 |
_a661-3 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aHoneywell, Richard J | |
| 773 | 0 |
_tExpert opinion on drug metabolism & toxicology _gvol. 11 _gno. 5 _gp. 661-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/17425255.2015.1041255 _zAvailable from publisher's website |
| 999 |
_c24867483 _d24867483 |
||